Cathepsin k deficiency prevents the aggravated vascular remodeling response to flow cessation in ApoE-/- Mice

PLoS ONE

Volumn 11, Issue 9, 2016, Pages

  Donners, Marjo M P C ^a   Bai, Lili ^a   Lutgens, Suzanne P M ^a   Wijnands, Erwin ^a   Johnson, Jason ^c   Schurgers, Leon J ^a   Liu, Cong Lin ^d   Daemen, Mat J A P ^a,b   Cleutjens, Kitty B J M ^a   Shi, Guo Ping ^d   Biessen, Erik A L ^a   Heeneman, Sylvia ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN K; APOLIPOPROTEIN E;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD FLOW; CAROTID ARTERY; CATHEPSIN K DEFICIENCY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME DEFICIENCY; HYPERLIPIDEMIA; IN VIVO STUDY; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MONOCYTE; MOUSE; NEOINTIMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; VASCULAR REMODELING; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; APOLIPOPROTEINS E; CATHEPSIN K; CELLS, CULTURED; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REGIONAL BLOOD FLOW; VASCULAR REMODELING;

EID: 84992379992     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0162595     Document Type: Article

References (30)

1. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, et al. Proteolytic activity of human osteoclast cathepsin K expression, purification, activation, and substrate identification. Journal of Biological Chemistry. 1996; 271(21):12517-24.
2. Kafienah W, Bromme D, Buttle D, Croucher L, Hollander A. Human cathepsin K cleaves native type I and II collagens at the N-Terminal end of the triple helix. Biochem J. 1998; 331:727-32.
3. Lutgens SP, Kisters N, Lutgens E, van Haaften RI, Evelo CT, de Winther MP, et al. Gene profiling of cathepsin K deficiency in atherogenesis: profibrotic but lipogenic. The Journal of pathology. 2006; 210 (3):334-43.
4. Asagiri M, Hirai T, Kunigami T, Kamano S, Gober H-Jr, Okamoto K, et al. Cathepsin K-dependent tolllike receptor 9 signaling revealed in experimental arthritis. Science. 2008; 319(5863):624-7. doi: 10. 1126/science.1150110
5. Lutgens E, Lutgens S, Faber B, Heeneman S, Gijbels M, de Winther M, et al. Disruption of the cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation. 2006; 113(1):98-107.
6. Clowes AW, Reidy M, Clowes M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Laboratory investigation; a journal of technical methods and pathology. 1983; 49(3):327-33.
7. Mehra M, Ventura H, Stapleton D, Smart F. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: A paradigm shift. The Journal of heart and lung transplantation: The official publication of the International Society for Heart Transplantation. 1995; 14(6 Pt 2):S207.
8. Cheng XW, Kuzuya M, Sasaki T, Arakawa K, Kanda S, Sumi D, et al. Increased expression of elastolytic cysteine proteases, cathepsins S and K, in the neointima of balloon-injured rat carotid arteries. The American journal of pathology. 2004; 164(1):243-51.
9. Ivan E, Khatri JJ, Johnson C, Magid R, Godin D, Nandi S, et al. Expansive Arterial Remodeling Is Associated With Increased Neointimal Macrophage Foam Cell Content The Murine Model of Macrophage-Rich Carotid Artery Lesions. Circulation. 2002; 105(22):2686-91.
10. Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, et al. Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. Proceedings of the National Academy of Sciences. 1998; 95(23):13453-8.
11. Kumar A, Lindner V. Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arteriosclerosis, thrombosis, and vascular biology. 1997; 17(10):2238-44.
12. Jofre-Monseny L, Minihane A-M, Rimbach G. Impact of apoE genotype on oxidative stress, inflammation and disease risk. Molecular nutrition & food research. 2008; 52(1):131-45.
13. Chazov EI, Bespalova JD, Arefieva TI, Kukhtina NB, Sidorova MV, Provatorov SI, et al. The peptide analogue of MCP-1 65-76 sequence is an inhibitor of inflammation Canadian journal of physiology and pharmacology. 2007; 85(3-4):332-40.
14. Ferns G, Forster L, Stewart-Lee A, Konneh M, Nourooz-Zadeh J, Anggrd E. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proceedings of the National Academy of Sciences. 1992; 89(23):11312-6.
15. Kukhtina N, Bashtrykov P, Bespalova ZD, Sidorova M, Aref'eva T, Sokolov V, et al. Effects of synthetic monocyte chemotactic protein-1 fragment 65-76 on neointima formation after carotid artery balloon injury in rats. Neuroscience and behavioral physiology. 2009; 39(2):153-9. doi: 10.1007/s11055-009-9112-z
16. MacKinnon AC, Farnworth SL, Hodkinson PS, Henderson NC, Atkinson KM, Leffler H, et al. Regulation of alternative macrophage activation by galectin-3. The Journal of Immunology. 2008; 180(4):2650-8.
17. Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis the good, the bad, and the ugly. Circulation research. 2002; 90(3):251-62.
18. Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, et al. The collagenolytic activity of cathepsin K is unique among mammalian proteinases. Journal of Biological Chemistry. 1998; 273 (48):32347-52.
19. Eschert H, Sindermann J, Scheld H, Breithardt G, Weissen-Plenz G. Vascular remodeling in ApoE-deficient mice: diet dependent modulation after carotid ligation. Atherosclerosis. 2009; 204(1):96-104. doi: 10.1016/j.atherosclerosis.2008.08.025
20. -/-and ApoE 3-Leiden Transgenic Mice. Arteriosclerosis, thrombosis, and vascular biology. 2001; 21(8):1359-65.
21. Lessner SM, Martinson DE, Galis ZS. Compensatory vascular remodeling during atherosclerotic lesion growth depends on matrix metalloproteinase-9 activity. Arteriosclerosis, thrombosis, and vascular biology. 2004; 24(11):2123-9.
22. Zouggari Y, Ait-Oufella H, Waeckel L, Vilar J, Loinard Cl, Cochain Cm, et al. Regulatory T cells modulate postischemic neovascularization. Circulation. 2009; 120(14):1415-25. doi: 10.1161/CIRCULATIONAHA.109.875583
23. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature Reviews Immunology. 2005; 5 (12):953-64.
24. Swirski FK, Libby P, Aikawa E, Alcaide P, Luscinskas FW, Weissleder R, et al. Ly-6Chi monocytes dominate hypercholesterolemia-Associated monocytosis and give rise to macrophages in atheromata. Journal of Clinical Investigation. 2007; 117(1):195.
25. Martinez FO, Sica A, Mantovani A, Locati M. Macrophage activation and polarization. Frontiers in bioscience. 2007; 13:453-61.
26. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nature Reviews Immunology. 2008; 8(12):958-69. doi: 10.1038/nri2448
27. Ostriker A, Horita HN, Poczobutt J, Weiser-Evans MC, Nemenoff RA. Vascular smooth muscle cellderived transforming growth factor-beta promotes maturation of activated, neointima lesion-like macrophages. Arterioscler Thromb Vasc Biol. 2014; 34(4):877-86. doi: 10.1161/ATVBAHA.114.303214 ; PubMed Central PMCID: PMC3966963.
28. Fortuna-Costa A, Gomes AM, Kozlowski EO, Stelling MP, Pavao MS. Extracellular galectin-3 in tumor progression and metastasis. Front Oncol. 2014; 4:138. doi: 10.3389/fonc.2014.00138 ; PubMed Central PMCID: PMC4058817.
29. Gong D, Shi W, Yi S-j, Chen H, Groffen J, Heisterkamp N. TGFbeta signaling plays a critical role in promoting alternative macrophage activation. BMC immunology. 2012; 13(1):31.
30. Hollestelle SC, de Vries MR, van Keulen JK, Schoneveld AH, Vink A, Strijder CF, et al. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation. 2004; 109(3):393-8.